phytic acid has been researched along with Aortic Diseases in 1 studies
Phytic Acid: Complexing agent for removal of traces of heavy metal ions. It acts also as a hypocalcemic agent.
myo-inositol hexakisphosphate : A myo-inositol hexakisphosphate in which each hydroxy group of myo-inositol is monophosphorylated.
Aortic Diseases: Pathological processes involving any part of the AORTA.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Grases, F | 1 |
| Sanchis, P | 1 |
| Perello, J | 1 |
| Isern, B | 1 |
| Prieto, RM | 1 |
| Fernandez-Palomeque, C | 1 |
| Saus, C | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Value of Oral Phytate (InsP6) in the Prevention of Progression of the Cardiovascular Calcifications[NCT01000233] | Phase 2/Phase 3 | 250 participants (Anticipated) | Interventional | 2009-08-31 | Recruiting | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
1 other study available for phytic acid and Aortic Diseases
| Article | Year |
|---|---|
Phytate reduces age-related cardiovascular calcification.
Topics: Administration, Oral; Aging; Animal Feed; Animals; Aorta; Aortic Diseases; Calcinosis; Cardiovascula | 2008 |